HELP

Cybin Inc

• Benzinga·05/08 16:02

  'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive

• TipRanks·05/04 20:28

  Helus Pharma Partners With TARA Mind to Boost Phase 3 Depression Trial in Veterans After U.S. Executive Order

• TipRanks·04/30 20:17

  Helus Pharma CEO to Spotlight Mental Health Innovation at 29th Milken Global Conference

• TipRanks·04/30 18:56

  Psychedelic: FDA awards Compass Pathways priority review voucher

• PUBT·04/30 11:37

  Cybin’s Helus Pharma joins Milken Institute Global Conference panel on health innovation

• TipRanks·04/28 19:47

  Helus Pharma Aligns With U.S. Veteran Mental Health Push in New TARA Mind Partnership

• TipRanks·04/28 16:35

  H.C. Wainwright Keeps Their Buy Rating on Helus Pharma (HELP)

• Seeking Alpha·04/27 15:48

  Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit

• Reuters·04/24 13:38

  BUZZ-Compass Pathways rises after FDA fast-tracks psychedelic drug research

• TipRanks·04/23 22:05

  Helus Pharma Adds Langer and Brannan to Advisory Board to Bolster Late-Stage Mental Health Pipeline

• Reuters·04/23 11:30

  HELUS PHARMA STRENGTHENS SCIENTIFIC ADVISORY BOARD WITH ADDITION OF DR. ROBERT LANGER AND DR. STEPHEN BRANNAN

• Seeking Alpha·04/21 19:51

  Cybin: Regulatory Tailwinds Unlock Asymmetric Upside (Rating Upgrade)

• TipRanks·04/20 21:48

  Helus Pharma Backs U.S. Executive Order Accelerating Psychedelic Treatment Pathways

• TipRanks·04/20 21:24

  Helus Pharma Names Co‑Founder Eric So Interim CEO as Board Ousts Michael Cola

• TipRanks·04/20 17:37

  H.C. Wainwright Sticks to Its Buy Rating for Helus Pharma (HELP)